Envoy Medical, Inc. (COCH)
 NASDAQ: COCH · Real-Time Price · USD
 0.7488
 -0.0356 (-4.54%)
  At close: Oct 30, 2025, 4:00 PM EDT
0.7480
 -0.0008 (-0.11%)
  After-hours: Oct 30, 2025, 7:27 PM EDT
Envoy Medical Revenue
Envoy Medical had revenue of $78.00K in the quarter ending June 30, 2025, with 14.71% growth. This brings the company's revenue in the last twelve months to $222.00K, down -26.49% year-over-year. In the year 2024, Envoy Medical had annual revenue of $225.00K, down -28.80%.
Revenue (ttm) 
 $222.00K
Revenue Growth 
 -26.49%
P/S Ratio 
 71.26
Revenue / Employee 
 $5,286
Employees 
 42
Market Cap 
21.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 225.00K | -91.00K | -28.80% | 
| Dec 31, 2023 | 316.00K | 79.00K | 33.33% | 
| Dec 31, 2022 | 237.00K | -73.00K | -23.55% | 
| Dec 31, 2021 | 310.00K | - | - | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCOCH News
- 1 day ago - Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant - Newsfile Corp
- 3 days ago - Envoy Medical Receives Positive Listing Determination from NASDAQ - Newsfile Corp
- 21 days ago - Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 22 days ago - Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 23 days ago - Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data - Newsfile Corp
- 23 days ago - Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data - Newsfile Corp
- 4 weeks ago - Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th - Newsfile Corp
- 5 weeks ago - Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile Corp